January 2012 -- Uniqsis of Cambridge, UK, and WaveCraft of Uppsala, Sweden, have entered into a collaborative agreement to develop and market a new range of microwave-based flow chemistry systems that will radically improve efficiency when scaling up compound synthesis during drug development.
By integrating proven liquid handling technology from Uniqsis with unique microwave applicator technology and reactors from WaveCraft, the two companies will deliver flow chemistry systems that not only speed up synthetic processes and facilitate scale up, but also offer a completely safe solution that uses significantly less energy than conventional approaches.
Flow chemistry and microwave synthesis systems have become well established in synthesis laboratories over the last 15 years. WaveCraft’s technology uses a novel applicator and a proprietary microwave generator based on mobile phone technology to apply microwave energy and accelerate chemical reactions. This makes it possible, for the first time, to effectively and safely combine flow chemistry with microwave heating. Scientists will be able to continuously change power and frequency, enabling optimisation during synthesis. They will be able to scale up with no need to re-optimise conditions.
Paul Pergande, MD of Uniqsis, comments: “The WaveCraft team is pre-eminent in the field of microwave technology and we believe that their new technology shows exceptional promise. We are very excited to be working with them on this novel approach to microwave-based synthesis which offers real benefits to customers.”
Jon-Sverre Schanche, CEO of WaveCraft, adds, “We are extremely pleased that the potential of our technology has been recognised by a company well-established in the field of flow synthesis. Working together will give both companies a great opportunity to offer customers solutions that significantly increase productivity”
About Uniqsis Ltd
Based near Cambridge, UK, Uniqsis was formed in January 2007 by Asynt Ltd and Grant Instruments (Cambridge) Ltd to develop innovative continuous flow chemistry products for customers in both the research and biopharmaceutical sectors. A consortium of expert engineers, supporting companies and scientists from the pharmaceutical industry has been assembled to provide in-depth scientific and technical expertise to the development of this exciting new technology.
For more information please contact:
Paul Pergande +44 (0)845 864 7747
Email: paul.pergande@uniqsis.com
www.uniqsis.com
About WaveCraft
WaveCraft has developed microwave-assisted technology to provide faster, safer and more environmentally friendly development and production of organic compounds. Current focus is on the pharmaceutical, biotech, and contract research and manufacturing organisations. The company envisions the application of this technology to large-scale production, leading to faster process development and production, a reduction in raw material consumption and significant reduction of waste.
For more information please contact:
John-Sverre Schanche +46 (0) 706 723632
E-mail jon-sverre.schanche@wavecraft.seH
www.wavecraft.se
